Cancer Family
Sarcoma
CI-CAN-00000344SARExplore in graph →
634 active trials17 approved drugs182 evidence items
- NCIt
- C9118
- OncoTree
- SARCNOS
- DOID
- 1115
- MeSH
- D012509
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000344SARExplore in graph →
Clinical trials
2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (365)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00864032 | Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall | completed | Phase 1 / Phase 2 | 8 | University of California, DavisOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00842452 | Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 26 | Steven Waggoner, MDOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00098579 | Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00027911 | Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma | terminated | Phase 1 | — | Columbia UniversityOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00024024 | BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma | completed | Phase 1 / Phase 2 | 59 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00002936 | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00003023 | Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00119301 | Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma | completed | Phase 1 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00102609 | A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma | completed | Phase 1 | 41 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Jan 10, 2013 | clinicaltrials |
| NCT00288444 | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | terminated | Phase 1 | 38 | Emory UniversityOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00837161 | Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids | completed | Phase 1 / Phase 2 | 11 | Philips HealthcareINDUSTRY | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 91 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00030784 | Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 28 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00003720 | SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00004109 | Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00492141 | Aerosol L9-NC and Temozolomide in Ewing's Sarcoma | completed | Phase 1 / Phase 2 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00004123 | Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma | completed | Phase 1 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01296659 | Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma | withdrawn | Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00032162 | Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer | completed | Phase 1 / Phase 2 | 63 | AGO Study GroupOTHER | 1 | May 31, 2012 | clinicaltrials |
| NCT00132158 | ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 19 | St. Jude Children's Research HospitalOTHER | 1 | Apr 17, 2012 | clinicaltrials |
| NCT00436657 | Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00030108 | Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | completed | Phase 1 | 30 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00036959 | ABT-751 in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 90 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00303940 | Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors | completed | Phase 1 | 26 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00006234 | Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 1, 2011 | clinicaltrials |
| NCT00051597 | A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies | completed | Phase 1 / Phase 2 | 70 | Seagen Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00023790 | Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00689195 | Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma(OSCAT) | unknown | Phase 1 / Phase 2 | 24 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00753727 | Sunitinib and Radiation in Patients With Resectable Soft-tissue Sarcoma(SUNXRT) | unknown | Phase 1 / Phase 2 | 26 | Australasian Sarcoma Study GroupOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00505713 | Safety and Efficacy Study Using Rexin-G for Sarcoma | completed | Phase 1 / Phase 2 | 36 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00004105 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00276302 | Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) | completed | Phase 1 | 63 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 6, 2011 | clinicaltrials |
| NCT00069940 | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | completed | Phase 1 | — | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00417807 | Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors | completed | Phase 1 / Phase 2 | 9 | Novartis PharmaceuticalsINDUSTRY | 1 | Dec 24, 2010 | clinicaltrials |
| NCT00179816 | Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | unknown | Phase 1 / Phase 2 | 12 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00003081 | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma | completed | Phase 1 | 16 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 20, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00118326 | Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | May 14, 2010 | clinicaltrials |
| NCT00289809 | TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients | completed | Phase 1 / Phase 2 | 36 | Istituto Clinico HumanitasOTHER | 1 | Dec 18, 2009 | clinicaltrials |
| NCT00006246 | Busulfan in Treating Children and Adolescents With Refractory CNS Cancer | completed | Phase 1 | 28 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00541840 | Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma | unknown | Phase 1 / Phase 2 | 24 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | May 12, 2008 | clinicaltrials |
| NCT00187109 | Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | completed | Phase 1 / Phase 2 | 40 | St. Jude Children's Research HospitalOTHER | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00001209 | A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors | completed | Phase 1 | 120 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001436 | A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001573 | A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001577 | Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001535 | Twins Study of Gene Therapy for HIV Infection | completed | Phase 1 | 48 | National Human Genome Research Institute (NHGRI)NIH | 1 | Feb 8, 2008 | clinicaltrials |
| NCT00188422 | Study of Low Dose CT in Sarcoma Patients | completed | Phase 1 | 70 | University Health Network, TorontoOTHER | 1 | Apr 23, 2007 | clinicaltrials |
| NCT00002136 | A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | completed | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 10, 2013source: clinicaltrials